Yingying Liu Selected Research

Yingying Liu Research Topics

Disease

38	Neoplasms (Cancer) 11/2022 - 02/2004
12	Inflammation (Inflammations) 06/2021 - 07/2014
9	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 09/2010
8	Ischemic Stroke 01/2022 - 07/2016
8	Multiple Sclerosis 01/2021 - 09/2010
7	Carcinogenesis 05/2021 - 02/2004
6	Hypoxia (Hypoxemia) 01/2022 - 04/2011
6	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 06/2013
5	Body Weight (Weight, Body) 01/2022 - 08/2010
5	Infections 01/2022 - 01/2002
5	Stroke (Strokes) 10/2021 - 03/2015
5	Glioma (Gliomas) 01/2020 - 07/2016
4	Myocardial Infarction 04/2022 - 01/2018
4	Fibrosis (Cirrhosis) 01/2021 - 10/2016
4	Neoplasm Metastasis (Metastasis) 11/2020 - 06/2013
4	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 01/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 09/2016
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2022 - 01/2017
3	Insulin Resistance 06/2022 - 11/2021
3	Type 2 Diabetes Mellitus (MODY) 06/2022 - 11/2021
3	Heart Failure 06/2021 - 10/2002
3	Hyperplasia 01/2021 - 01/2020
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 05/2015
3	Chronic Obstructive Pulmonary Disease (COPD) 04/2020 - 02/2013
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 03/2018
2	Melanoma (Melanoma, Malignant) 11/2022 - 06/2022
2	Cicatrix (Scar) 09/2022 - 03/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022 - 08/2015
2	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 01/2020
2	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2022 - 01/2020
2	Ischemia 01/2022 - 01/2018
2	Lung Injury 01/2022 - 01/2018
2	Cognitive Dysfunction 01/2022 - 01/2020
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2021
2	Membranous Glomerulonephritis (Membranous Nephropathy) 12/2021 - 01/2019
2	COVID-19 12/2021 - 06/2021
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2021 - 01/2019
2	Chronic Renal Insufficiency 11/2021 - 01/2019
2	Idiopathic Pulmonary Fibrosis 10/2021 - 01/2021
2	Hepatitis B 01/2021 - 10/2020
2	Obesity 01/2021 - 11/2018
2	Breast Neoplasms (Breast Cancer) 11/2020 - 02/2004
2	B-Cell Lymphoma (Lymphoma, B Cell) 11/2020 - 09/2016
2	Multiple Myeloma 01/2020 - 02/2016
2	Autoimmune Diseases of the Nervous System 01/2020 - 01/2020
2	Hypersensitivity (Allergy) 01/2020 - 01/2019
2	Liver Neoplasms (Liver Cancer) 01/2020 - 12/2015
2	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 11/2016

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 06/2022 - 08/2010
10	Pharmaceutical PreparationsIBA 07/2022 - 08/2013
8	CytokinesIBA 01/2022 - 01/2002
7	Biological ProductsIBA 03/2022 - 01/2017
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2013
7	Long Noncoding RNAIBA 01/2022 - 07/2016
6	LipidsIBA 01/2022 - 04/2016
6	CateninsIBA 08/2020 - 12/2015
5	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2016
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2017 - 02/2004
4	EnzymesIBA 06/2022 - 04/2016
4	Interleukin-17 (Interleukin 17)IBA 01/2022 - 05/2017
4	Minocycline (Cyclops)FDA LinkGeneric 05/2015 - 09/2010
3	Polysaccharides (Glycans)IBA 07/2022 - 01/2020
3	NucleotidesIBA 01/2022 - 01/2017
3	Triglycerides (Triacylglycerol)IBA 01/2022 - 07/2014
3	Messenger RNA (mRNA)IBA 01/2022 - 09/2010
3	OsteopontinIBA 01/2021 - 03/2015
3	Circular RNAIBA 01/2021 - 01/2019
3	IronIBA 01/2021 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2018
3	TNF Receptor-Associated Factor 3IBA 01/2021 - 02/2016
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2015 - 09/2010
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 12/2021 - 01/2021
2	NF-kappa B (NF-kB)IBA 12/2021 - 09/2021
2	Epidermal Growth Factor (EGF)IBA 12/2021 - 01/2018
2	Phosphotransferases (Kinase)IBA 12/2021 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 01/2021
2	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2021 - 01/2021
2	Carrier Proteins (Binding Protein)IBA 10/2021 - 01/2016
2	Capsules (Microcapsules)IBA 09/2021 - 01/2019
2	AntibodiesIBA 04/2021 - 01/2018
2	Peptides (Polypeptides)IBA 04/2021 - 01/2021
2	Mitogen-Activated Protein KinasesIBA 01/2021 - 08/2020
2	Therapeutic UsesIBA 01/2021 - 06/2011
2	Small Interfering RNA (siRNA)IBA 11/2020 - 06/2013
2	salicylhydroxamic acid (SHAM)IBA 08/2020 - 08/2010
2	Environmental Pollutants (Pollutants, Environmental)IBA 01/2020 - 12/2016
2	Choline (Choline Chloride)IBA 01/2020 - 12/2015
2	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 03/2018
2	RNA (Ribonucleic Acid)IBA 01/2020 - 10/2016

Therapy/Procedure

14	Therapeutics 09/2022 - 09/2010
7	Chinese Traditional Medicine (Traditional Chinese Medicine) 07/2022 - 02/2013
5	Drug Therapy (Chemotherapy) 03/2022 - 07/2008
4	Immunotherapy 11/2022 - 08/2013
4	Radiotherapy 01/2019 - 01/2017
3	Microbubbles 04/2021 - 07/2016
3	Injections 03/2020 - 05/2017
2	Fecal Microbiota Transplantation 01/2021 - 01/2020